Protalix BioTherapeutics - 53 Year Dividend History | PLX

Historical dividend payout and yield for Protalix BioTherapeutics (PLX) since 1971. The current TTM dividend payout for Protalix BioTherapeutics (PLX) as of April 18, 2024 is $0.00. The current dividend yield for Protalix BioTherapeutics as of April 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.084B $0.065B
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.
Stock Name Country Market Cap PE Ratio